Preventing complications in cardiac pacemaker therapy: a lifecycle-based risk management framework - Report - MDSpire

Preventing complications in cardiac pacemaker therapy: a lifecycle-based risk management framework

  • By

  • Yue Li

  • Rui Li

  • Jun Zhang

  • Xin Yang

  • Luhui Gan

  • Yu Liao

  • Hua He

  • Lingyun Jiang

  • Xin Zhang

  • June 1, 2026

  • 0 min

Share

Clinical Report: Mitigating Risks in Cardiac Pacemaker Treatment

Overview

This review discusses the increasing incidence of pacemaker-related complications and proposes a lifecycle-based risk management framework for their prevention.

Background

Pacemaker implantation is a critical intervention for managing bradyarrhythmias and conduction disorders, with rising global usage. Despite their efficacy, complications associated with pacemakers can significantly affect patient outcomes and healthcare costs.

Data Highlights

No specific numerical data provided in the source material.

Key Findings

['Pacemaker-related complications vary widely in incidence and impact across different patient populations.', 'Complications can arise from procedural factors, device dysfunction, infections, and structural heart changes.', 'A lifecycle risk management framework is proposed to enhance complication prevention throughout the continuum of pacemaker therapy.', 'Different types of complications are associated with distinct risk profiles and clinical contexts.', 'Structured preprocedural assessments and standardized intraoperative techniques are critical for reducing complication rates.']

Clinical Implications

Continuous monitoring and management strategies are essential for patients with pacemakers.

Conclusion

A comprehensive lifecycle risk management framework for pacemaker therapy is proposed.

Related Resources & Content

  1. European Journal of Preventive Cardiology, 2025 -- Risk assessment and prevention in cardiomyopathies
  2. Clinical Research in Cardiology, 2024 -- Impact of Comorbidity on Mortality and Readmission Rates in Patients with Existing Implantable Pacemakers Undergoing Catheter Ablation
  3. Clinical Research in Cardiology, 2017 -- Assessment of Life-Threatening Arrhythmia Risk in Newly Diagnosed Peripartum Cardiomyopathy with Reduced Ejection Fraction
  4. Frontiers in Digital Health, 2026 -- Lifecycle Strategies for Evidence, Change Management, and Post-Market Validation of AI-Driven Cardiovascular Devices
  5. ESC 365, 2025 -- Cardiac implantable electronic device upgrades and downgrades: a Clinical Consensus Statement of the European Heart Rhythm Association
  6. Groundbreaking consensus statement on conduction system pacing released: a major milestone in the evolution of pacing therapy
  7. AHA Update on CIED Infection Prevention and Management: Key Points - American College of Cardiology
  8. ESC 365 - Cardiac implantable electronic device upgrades and downgrades: a Clinical Consensus Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Asia Pacific Heart Rhythm Association (APHRS), Canadian Heart Rhythm Society (CHRS), Heart Rhythm Society (HRS), and the Latin American Heart Rhythm Society (LAHRS)
  9. Groundbreaking consensus statement on conduction system pacing released: a major milestone in the evolution of pacing therapy
  10. AHA Update on CIED Infection Prevention and Management: Key Points - American College of Cardiology
  11. Dual-Chamber Leadless Pacemakers Are Possible! | NEJM Clinician
  12. Systematic Review and Meta-Analysis of Acute Mortality and Complication Rates Following Leadless Pacemaker Placement Using National-Level Data | MDPI
  13. A Modular Communicative Leadless Pacing–Defibrillator System | New England Journal of Medicine
  14. Clinical effectiveness and safety of transvenous lead extraction of very old leads - PubMed
  15. Quality ID #393: Infection within 180 Days of Cardiac Implantable Electronic Device (CIED)

Original Source(s)

Related Content